NYSE : PRGO
Perrigo Company plc — Key statistics
Healthcare · Drug Manufacturers - Specialty & Generic · Ireland
Last price 15.87 USD (Nov 2, 2026, 11:39 AM EST) · Market cap 2.20B
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Key statistics
Valuation
| Measure | Value |
|---|
| Market Cap | 2.19B |
| Enterprise Value | 5.26B |
Dates
| Measure | Value |
|---|
| Earnings Date | Nov 4, 2026 |
| Ex-Dividend Date | Nov 27, 2026 |
Shares
| Measure | Value |
|---|
| Current Share Class | 138.77M |
| Shares Outstanding | 138.77M |
| Shares Change (YoY) | +0.73% |
| Shares Change (QoQ) | +0.65% |
| Owned by Insiders (%) | 0.47% |
| Owned by Institutions (%) | 111.56% |
| Float | 138.07M |
Ratios
| Measure | Value |
|---|
| PE Ratio | n/a |
| Forward PE | 6.98 |
| PS Ratio | 0.53 |
| Forward PS | 0.51 |
| PB Ratio | 0.87 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 18.36 |
| P/OCF Ratio | 11.17 |
| PEG Ratio | n/a |
Evratios
| Measure | Value |
|---|
| EV / Earnings | n/a |
| EV / Sales | 1.27 |
| EV / EBITDA | 8.56 |
| EV / EBIT | 18.84 |
| EV / FCF | 44.15 |
Financialposition
| Measure | Value |
|---|
| Current Ratio | 2.32 |
| Quick Ratio | 1.09 |
| Debt / Equity | 1.38 |
| Debt / EBITDA | 5.24 |
| Debt / FCF | 29.14 |
| Interest Coverage | 1.40 |
Financialefficiency
| Measure | Value |
|---|
| Return on Equity (ROE) | -48.75% |
| Return on Assets (ROA) | 1.97% |
| Return on Invested Capital (ROIC) | 4.83% |
| Return on Capital Employed (ROCE) | 4.26% |
| Weighted Average Cost of Capital (WACC) | 5.89% |
| Revenue Per Employee | $511,716 |
| Profits Per Employee | -$214,160 |
| Employee Count | 8,100 |
| Asset Turnover | 0.47 |
| Inventory Turnover | 2.43 |
Taxes
| Measure | Value |
|---|
| Income Tax | 90.70M |
| Effective Tax Rate | n/a |
Stockprice
| Measure | Value |
|---|
| Beta (5Y) | 0.69 |
| 52-Week Price Change | -23.96% |
| 50-Day Moving Average | 14.86 |
| 200-Day Moving Average | 12.45 |
| Relative Strength Index (RSI) | 55.10 |
| Average Volume (20 Days) | 2,393,889 |
Shortselling
| Measure | Value |
|---|
| Short Interest | 24.18M |
| Short Previous Month | 22.64M |
| Short % of Shares Out | 17.42% |
| Short % of Float | 17.51% |
| Short Ratio (days to cover) | 8.12 |
Incomestatement
| Measure | Value |
|---|
| Revenue | 4.14B |
| Gross Profit | 1.38B |
| Operating Income | 279.50M |
| Pretax Income | -1.61B |
| Net Income | -1.73B |
| EBITDA | 615.50M |
| EBIT | 279.50M |
| Loss Per Share | -$12.49 |
Balancesheet
| Measure | Value |
|---|
| Cash & Cash Equivalents | 399.70M |
| Total Debt | 3.48B |
| Net Cash | -3.08B |
| Net Cash Per Share | -$22.17 |
| Equity (Book Value) | 2.52B |
| Book Value Per Share | 18.14 |
| Working Capital | 1.40B |
Cashflow
| Measure | Value |
|---|
| Operating Cash Flow | 196.10M |
| Capital Expenditures | -76.80M |
| Depreciation & Amortization | 336.00M |
| Net Borrowing | -348.90M |
| Free Cash Flow | 119.30M |
| FCF Per Share | $0.86 |
Margins
| Measure | Value |
|---|
| Gross Margin | 33.26% |
| Operating Margin | 6.74% |
| Pretax Margin | -38.90% |
| Profit Margin | -41.85% |
| EBITDA Margin | 14.85% |
| EBIT Margin | 6.74% |
| FCF Margin | 2.88% |
Dividends
| Measure | Value |
|---|
| Dividend Per Share | $1.16 |
| Dividend Yield | 7.37% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | 22 |
| Payout Ratio | n/a |
| FCF Payout Ratio | 134.93% |
| Buyback Yield | -0.73% |
| Shareholder Yield | 6.65% |
| Earnings Yield | -79.29% |
| FCF Yield | 5.45% |
Analystforecasts
| Measure | Value |
|---|
| Price Target | $18.00 |
| Price Target Difference | 14.29% |
| Analyst Consensus | Hold |
| Analyst Count | 4 |
| Revenue Growth Forecast (3Y) | -0.89% |
| EPS Growth Forecast (3Y) | -0.89% |
Stocksplits
| Measure | Value |
|---|
| Last Split Date | Aug 26, 1993 |
| Split Type | Forward |
| Split Ratio | 2:1 |
Scores
| Measure | Value |
|---|
| Altman Z-Score | 0.42 |
| Piotroski F-Score | 6 |
Fairvalue
| Measure | Value |
|---|
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |